XML 27 R17.htm IDEA: XBRL DOCUMENT v3.25.2
Debt
 6 Months Ended
Jun. 30, 2025
Debt  
Debt

10.  Debt

Debt consists of the following:

​

​

​

​

​

​

​

​

​

​

June 30, 

​

December 31, 

​

    

2025

    

2024

​

​

(in millions)

Holding Company:

​

​

  

​

​

  

6.250% senior notes due 2026

​

$

719

​

$

719

5.250% senior notes due 2027

​

 

1,384

​

 

1,384

4.375% senior notes due 2029

​

​

656

​

​

656

9.750% senior notes due 2029

​

​

698

​

​

698

10.000% senior notes due 2029

​

​

495

​

​

495

9.000% senior notes due 2030

​

​

712

​

​

747

​

​

 

4,664

​

 

4,699

Reporting Segments:

​

​

​

​

​

​

Energy

​

 

1,861

​

 

1,919

Automotive

​

 

25

​

 

31

Food Packaging

​

 

147

​

 

144

Real Estate

​

 

1

​

 

1

Home Fashion

​

 

15

​

 

15

​

​

 

2,049

​

 

2,110

Total Debt

​

$

6,713

​

$

6,809

​

​

Holding Company

​

In June 2025, we repurchased in the open market approximately $35 million aggregate principal amount of our 9.000% senior notes due 2030 for total cash paid of $32 million. The repurchased notes were extinguished but were not retired and are held in treasury.

​

Energy

​

In June 2025, certain of our Energy segment’s subsidiaries (the “Term Loan Borrowers”) prepaid $70 million in principal amount of the senior secured term loan facility (the “Term Loan”). As a result of this transaction, CVR Energy recognized a $1 million loss on extinguishment of debt for the six months ended June 30, 2025.

As of June 30, 2025, total availability under CVR Energy’s Amended and Restated ABL Credit Agreement (“CVR Energy ABL”) and CVR Partners’ ABL Credit Agreement (“CVR Partners ABL”) facilities aggregated to $324 million. The CVR Energy ABL had $24 million of letters of credit outstanding as of June 30, 2025. The CVR Energy ABL matures on June 30, 2027, and the CVR Partners ABL on September 26, 2028.

Covenants

We and all of our subsidiaries are currently in compliance with all covenants and restrictions as described in the various executed agreements and contracts with respect to each debt instrument. These covenants include limitations on indebtedness, liens, investments, acquisitions, asset sales, dividends and other restricted payments and affiliate and extraordinary transactions. In July 2025, Viskase entered into an amendment to its credit agreement providing for, among other things, a waiver of any events of default relating to financial covenants under the credit agreement for the measurement period ended June 30, 2025, and consenting to the merger of Viskase with Enzon Pharmaceuticals, Inc.

Non-Cash Charges to Interest Expense

The amortization of deferred financing costs and debt discounts and premiums included in interest expense in the condensed consolidated statements of operations were $2 million and $1 million for the three months ended June 30, 2025 and 2024, respectively, and $3 million and $2 million for the six months ended June 30, 2025 and 2024, respectively.